# A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma

> **NCT00319683** · PHASE1,PHASE2 · TERMINATED · sponsor: **Adherex Technologies, Inc.**

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** ADH300004

## Key facts

- **NCT ID:** NCT00319683
- **Lead sponsor:** Adherex Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Why stopped:** Lack of funds
- **Last updated:** 2008-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00319683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00319683, "A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00319683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*